Nexstim discloses Kyösti Kakkonen's holdings below 5%
The notification was received on 17 July 2026 regarding a threshold crossing.
See the latest news and media coverage for Nexstim. We track all announcements, press releases, and industry mentions in real time, all in one place.
Navigated transcranial magnetic stimulation systems provider
nexstim.comLast updated
In short: Nexstim achieved profitability in 2025 and secured a €5 million investment while expanding its NBS 6 system's global regulatory reach.
The notification was received on 17 July 2026 regarding a threshold crossing.
The order reflects continued demand and follows a previous order from the distributor.
This includes diagnostic mapping and chronic neuropathic pain treatment, building on prior MDD approval.
The Malaysian Medical Device Authority approved NBS 6 for diagnostic and therapy applications in Malaysia.
Nexstim Plc ("Nexstim" or "Company") has received a notification pursuant to chapter 9, section 5 of the Securities Market Act on 17 July 2026. According...
The Finnish medical technology company Nexstim has received a new order for ten NBS 6 systems from a distributor. Deliveries are planned for the second half of 2026.
Nexstim Plc ("Nexstim" or "the Company") has received a notification under Chapter 9, Section 5 of the Securities Markets Act on 15 May 2026. According to the notification, Eiffel Investment Group's holding of Nexstim's shares and votes...
Nexstim Plc (" Nexstim " or " Company ") has received a notification pursuant to chapter 9, section 5 of the Securities Market Act on...
Track Nexstim and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Nexstim and other trending companies.